GLP-1 Drugs Just Broke The Global Whey Market: Prices Up 250%, No Relief Till 2027

Posted on by

(SeaPRwire) –   By: Jeremy Vance

Most people don’t connect weight loss jabs to their morning cereal or post-gym protein shake. But right now, a wild demand shock is sending global whey prices through the roof. U.S. 80% whey protein concentrate, the most common grade, is up 250% year over year, trading over $13 a pound on dairy commodity markets. This isn’t a temporary blip from bad weather or port delays. It’s a cascading shift in consumer behavior that caught the entire global supply chain completely napping.

The average U.S. supermarket now carries 38,708 products that advertise added protein, per NielsenIQ. Whey is just a byproduct of industrial cheese making. Every pound of cheese yields nine pounds of whey, according to the USDA. For decades, U.S. dairy producers shipped excess whey to China. That flow all but stopped cold this year. U.S. exports of 80% whey concentrate and isolate to China dropped 47% between January and April, versus the same period last year. Domestic demand now eats up every bit of available supply.

The biggest surprise driver of this boom is the rise of GLP-1 weight loss drugs like Wegovy and Zepbound. These drugs suppress appetite, so users are told to eat nutrient-dense, high-protein food to retain muscle while losing weight. Morgan Stanley estimates 6% of U.S. obese and diabetic patients used GLP-1s last year. Some counts put total U.S. adult use as high as 12%. Food companies are rushing to add whey to everything from chips to Starbucks drinks to grab these new consumers.

Europe is feeling the same crunch. In late May, 80% whey hit a record 26,450 euros per metric ton, more than double what it cost less than a year ago. China has turned to Europe for supplies after U.S. exports dried up, worsening the shortage there. U.S. supplement brand Now Foods already raised whey prices earlier this year, after two years of rising raw material costs. Some brands are cutting discounts and testing cheaper alternatives like milk protein concentrate to offset rising costs.

Producers know demand is outstripping supply, so they are investing in new processing capacity. But new plants don’t open overnight. Irish nutrition firm Glanbia is expanding whey isolate production in New Mexico, but the extra capacity won’t come online until 2027. Other producers in Canada and the U.S. are adding capacity too, but all are at least two years out. Higher prices are already starting to cool some consumer demand, especially as overall grocery costs keep climbing.

Most mainstream food brands will quietly cut the labeled protein content of their “high-protein” products over the next 18 months to offset this shortage.

Author bio: Jeremy Vance, global FMCG supply chain auditor and industry analyst focused on consumer commodity price shifts.